NASDAQ: PTGXProtagonist Therapeutics Inc Stock Ownership - Who owns Protagonist Therapeutics?
Insider buying vs selling
Have Protagonist Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| William D. Waddill | Director | 2025-10-10 | 8,000 | $87.81 | $702.48kSell |
| William D. Waddill | Director | 2025-10-10 | 12,000 | $6.98 | $83.76kBuy |
| William D. Waddill | Director | 2025-10-10 | 4,000 | $69.25 | $277.00kSell |
| William D. Waddill | Director | 2025-09-22 | 4,000 | $64.25 | $257.00kSell |
| William D. Waddill | Director | 2025-08-27 | 4,000 | $59.25 | $237.00kSell |
| Dinesh V. Ph D. Patel | President and CEO | 2025-07-25 | 10,415 | $54.78 | $570.53kSell |
| Dinesh V. Ph D. Patel | President and CEO | 2025-07-23 | 17,520 | $54.79 | $959.92kSell |
| Dinesh V. Ph D. Patel | President and CEO | 2025-07-22 | 22,065 | $55.05 | $1.21MSell |
| Dinesh V. Ph D. Patel | President and CEO | 2025-07-21 | 12,859 | $54.86 | $705.44kSell |
| Arturo Md Molina | Chief Medical Officer | 2025-06-10 | 10,000 | $8.04 | $80.40kBuy |
PTGX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PTGX insiders and whales buy or sell their stock.
PTGX Shareholders
What type of owners hold Protagonist Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 15.48% | 9,630,341 | $757.14M | Institution |
| Farallon Capital Management LLC | 9.92% | 6,172,006 | $485.24M | Institution |
| Rtw Investments LP | 9.25% | 5,756,277 | $452.56M | Institution |
| Vanguard Group Inc | 7.01% | 4,358,595 | $342.67M | Institution |
| Deep Track Capital LP | 5.22% | 3,245,899 | $255.19M | Institution |
| Bvf Inc | 5.16% | 3,211,041 | $252.45M | Institution |
| State Street Corp | 5.16% | 3,207,543 | $252.18M | Institution |
| Ubs Group Ag | 4.02% | 2,501,251 | $196.65M | Institution |
| Julie Papanek | 3.94% | 2,453,255 | $192.87M | Insider |
| Johnson Johnson | 3.94% | 2,449,183 | $192.55M | Insider |
PTGX vs Biotech Stocks
Protagonist Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.